McKesson Europe AG
XHAM:CLS1
McKesson Europe AG
Research & Development
McKesson Europe AG
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
McKesson Europe AG
XHAM:CLS1
|
Research & Development
-€2.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
Medios AG
XETRA:ILM1
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Haemato AG
XETRA:HAEK
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is McKesson Europe AG's Research & Development?
Research & Development
-2.2m
EUR
Based on the financial report for Mar 31, 2022, McKesson Europe AG's Research & Development amounts to -2.2m EUR.
What is McKesson Europe AG's Research & Development growth rate?
Research & Development CAGR 5Y
15%
Over the last year, the Research & Development growth was 0%. The average annual Research & Development growth rates for McKesson Europe AG have been 22% over the past three years , 15% over the past five years .